FindMyKOL

Scott Coven, DO

Enriched profile

Associate Professor of Clinical Pediatrics, Riley Hospital for Children · Riley Hospital for Children

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Indianapolis, IN · Midwest · United StatesSpecialtyHematology / OncologyFocusGlioma Diagnosis and Treatment+4
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNone verifiedPayments2024–2025NIH fundingNone on fileWhy? →

Scott Coven is Associate Professor of Clinical Pediatrics, Riley Hospital for Children at Riley Hospital for Children. OpenAlex indexes 73 publications with 828 citations (h-index 11); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 4 Nov 2026

Overview

Updated 4 Nov 2026

{"value": "Scott L. Coven, D.O., is Associate Professor of Clinical Pediatrics, Riley Hospital for Children. The public record shows 73 publications with 828 citations (h-index 11), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 2 companies.

  • Most recent indexed publication: 2025 · Neuro-oncology pediatrics
  • Top research focus: Glioma Diagnosis and Treatment
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 4 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma3 trialsGlioma3 trialsDiffuse Intrinsic Pontine Glioma1 trialAstrocytoma1 trialEpilepsyAcromegalySarcomaSepsis / Serious BacterialLeukemia (AML/ALL/CML/CLL)ESRD / DialysisOvarian / Gynecologic CancerCOVID-19

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchChildhood Cancer Survivors' Quality of LifeGlobal Cancer Incidence and ScreeningVaccine Coverage and Hesitancy

Drugs & molecules

across trials, industry payments and publications
Ojemdageneric · TovorafenibClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Day One BiopharmaceuticalsClinical trials—Industry payments4University of California, San FranciscoClinical trials2Industry payments—Indiana UniversityClinical trials1Industry payments—Jazz Pharmaceuticals Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
73publications

Publications indexed by OpenAlex, matched via ORCID. 9 in PubMed. Counts exclude supporting files.

828citations

Citations across these publications.

11h-index

H-index from these publications. i10-index 13.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2024–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 4 Nov 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 4 Nov 2026

2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 4 Nov 2026

8 congress contributions (2020–2026) across AAN, ASCO, SAHM Annual Meeting, SNO per OpenAlex. The most recent:

All 8 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 4 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 9 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
All 73 cited works: search, sort and filter.Explore →

Network

Updated 4 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jonathan L. Finlay21Sarah E. S. Leary14Ute Katharina Bartels12Éric Bouffet11Diana S. Osorio10Jordan R. Hansford10Daniel R. Boué10Roger J. Packer9Joseph R. Stanek8Kathleen McCarthy O'Toole Dorris8Mahvish Qureshi Rahim8Carl Johannes Koschmann7Robert J. Greiner7Álvaro Lassaletta7Mary A. Ott7Gregory D. Zimet7Christopher L. Tinkle7Seethal A. Jacob7Maryam Fouladi7Cynthia E Hawkins7Paul Graham Fisher6Eric S. Sandler6Nicholas G. Gottardo6Michelle Monje6Hetal Dholaria6David Simon Ziegler6Tim Hassall6Lars M. Wagner6Adam Lane6Jane E. Minturn6Brooklyn Chaney6Pratiti Bandopadhayay6Minda Okemwa6Yvan Samson6Blaise V. Jones5Karen Tsui5Sylvia S. Cheng5Eneida A. Mendonça5Philip Mwachaka5

Online presence

Updated 4 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    pnoc.us/industry-leaders/scott-l-coven-do-mph

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pnoc.us ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 4 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Assistant Professor of Pediatrics

    Division of Pediatric Hematology-Oncology, Indiana University School of Medicine (earlier title per PNOC page)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pnoc.us ↗
  • Principal Investigator

    Pediatric Hematologist/Oncologist (Pacific Neuro-Oncology Consortium site, Riley Hospital for Children)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pnoc.us ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.